Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Sep 29;102(39):e35094. doi: 10.1097/MD.0000000000035094

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.

PMC Copyright notice

Figure 1. — Changes in symptom scores in each coronavirus disease 2019 (COVID-19) rebound patient. Changes in symptom scores in patients with COVID-19 rebound over time after antiviral therapy initiation. Each number represents a patient with COVID-19 rebound. The blue graphs show symptom scores for patients treated with nirmatrelvir-ritonavir. The red graphs show the symptom scores of patients treated with molnupiravir. The y-axis denotes the symptom scores, and the x-axis denotes the number of d since the start of the antiviral therapy. Additional tick between d 7 and 14 without a number on the x-axis indicates the d of clinical rebound for each patient. For patients #4, #7, and #11, the d of clinical rebound is d 14.